renal disease
Conditions
Interventions
None listed
Sponsors
Kawashima Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients undergoing renal biopsy in our hospital and healthy volunteers (according to the severity classification of chronic kidney disease; G1A1, G2A1)
Exclusion criteria
Exclusion criteria: patients who do not agree to participate in this study and patients who are considered unsuitable for research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| shear wave velocity and elastic modulus performed prior to renal biopsy | — |
Secondary
| Measure | Time frame |
|---|---|
| renal biopsy tissue score (glamellar cell progression, segmental bombage, global sclaimis, internal infrastructure cell infrabation, internal fiscal, rent tubular attropy, vessel walling, hellod deaths, hellod degenerate oftarities), urine osmotic pressure, ultrasound findings (renal size, marginal properties, corruginal contrast, real luminance, RI, PSV, depth), diagnosis with renal biopsy, CKD stage, Cr, BUN, eGFR, 24-hour creatine clearance, UA, Ca, Hb, Ht, Glu, HbA1c, T-Cho, LDL-C, HDL-C, TG, beta2-MG, urine beta2-MG, urine NAG, urine protein/Cr ratio, urine protein, urinary occult blood, BMI, blood pressure, FMD (Flow Mediated Dilation) | — |
Countries
Japan
Contacts
Public ContactChiaki Masaki
Kawashima Hospital Department of Laboratory
Outcome results
None listed